Translocation of lysophosphatidic acid phosphatase in response to gonadotropin-releasing hormone to the plasma membrane in ovarian cancer cell.
暂无分享,去创建一个
T. Furui | A. Morris | M. Saio | Andrew J Morris | Teruhiko Tamaya | Wen-Shu Sun | Atsushi Imai | Michiyo Sugiyama | Tatsuro Furui | Masanao Saio | T. Tamaya | A. Imai | Wenshu Sun | M. Sugiyama
[1] G. Mills,et al. Lysophospholipids activate ovarian and breast cancer cells. , 1995, The Biochemical journal.
[2] A. Schally,et al. Growth-Inhibitory Actions of Analogues of Luteinizing Hormone Releasing Hormone on Tumor Cells , 1997, Trends in Endocrinology & Metabolism.
[3] S. Rodenhuis,et al. Growth factors in human ovarian cancer. , 1997, Cancer treatment reviews.
[4] M. Key,et al. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[5] G. Mills,et al. Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancer. , 2002, Cancer treatment and research.
[6] T. Fuseya,et al. Signal transduction of GnRH receptor in the reproductive tract tumor. , 1996, Endocrine journal.
[7] A. Morris,et al. Role of phosphatidic acid phosphatase 2a in uptake of extracellular lipid phosphate mediators. , 2000, Biochimica et biophysica acta.
[8] M. Gershengorn,et al. Independent phosphatidylinositol synthesis in pituitary plasma membrane and endoplasmic reticulum , 1987, Nature.
[9] O. Kranenburg,et al. Lysophosphatidic acid: G-protein signalling and cellular responses. , 1997, Current opinion in cell biology.
[10] M. Gershengorn,et al. Measurement of lipid turnover in response to thyrotropin-releasing hormone. , 1987, Methods in enzymology.
[11] S. Hsu,et al. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. , 1981, American journal of clinical pathology.
[12] T. Furui,et al. Gonadotropin‐releasing hormone receptor in gynecologic tumors. Frequent expression in adenocarcinoma histologic types , 1994, Cancer.
[13] M. Kai,et al. Cloning and Characterization of Two Human Isozymes of Mg2+-independent Phosphatidic Acid Phosphatase* , 1997, The Journal of Biological Chemistry.
[14] M Markman,et al. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. , 1998, JAMA.
[15] T. Hla,et al. Lysophospholipids--Receptor Revelations , 2001, Science.
[16] G. Mills,et al. A putative new growth factor in ascitic fluid from ovarian cancer patients: identification, characterization, and mechanism of action. , 1988, Cancer research.
[17] G. Carman,et al. Lipid phosphate phosphohydrolase-1 degrades exogenous glycerolipid and sphingolipid phosphate esters , 1999 .
[18] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[19] A. Podtelejnikov,et al. Endophilin I mediates synaptic vesicle formation by transfer of arachidonate to lysophosphatidic acid , 1999, Nature.
[20] A. Morris,et al. Human Type 2 Phosphatidic Acid Phosphohydrolases , 1998, The Journal of Biological Chemistry.
[21] T. Tamaya,et al. Evidence for tight coupling of gonadotropin-releasing hormone receptor to stimulated Fas ligand expression in reproductive tract tumors: possible mechanism for hormonal control of apoptotic cell death. , 1998, The Journal of clinical endocrinology and metabolism.
[22] D. Brindley,et al. Mammalian Lipid Phosphate Phosphohydrolases* , 1998, The Journal of Biological Chemistry.
[23] G. Mills,et al. A gonadotropin-releasing hormone-responsive phosphatase hydrolyses lysophosphatidic acid within the plasma membrane of ovarian cancer cells. , 2000, The Journal of clinical endocrinology and metabolism.
[24] T. Morimoto,et al. The Dri 42 Gene, Whose Expression Is Up-regulated during Epithelial Differentiation, Encodes a Novel Endoplasmic Reticulum Resident Transmembrane Protein* , 1996, The Journal of Biological Chemistry.
[25] G. Mills,et al. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[26] A. Morris,et al. Sequential actions of phospholipase D and phosphatidic acid phosphohydrolase 2b generate diglyceride in mammalian cells. , 1999, Molecular biology of the cell.
[27] G. Mills,et al. Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells. , 1990, The Journal of clinical investigation.
[28] G. Mills,et al. Peptide and lipid growth factors decrease cis-diamminedichloroplatinum-induced cell death in human ovarian cancer cells. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[29] T. Tamaya,et al. GnRH receptor and apoptotic signaling. , 2000, Vitamins and hormones.